Rancati V, Scala E, Ltaief Z, Gunga MZ, Kirsch M, Rosner L, et al. Challenges in patient blood management for cardiac surgery: a narrative review. J Clin Med. 2021;10(11):2454.
Google Scholar
Chen W, Jin K, Yu Z, Liu H. Analysis of risk factors and management of unexpected intraoperative bleeding during video-assisted thoracic surgery for non-small cell lung cancer: a case-control study. J Thorac Dis. 2023;15(5):2729–41.
Google Scholar
Comanici M, Raja SG. Iatrogenic coronary artery injuries during non-coronary artery adult cardiac surgery. AME Med J. 2023;8:12–12.
Pagano D, Milojevic M, Meesters MI, Benedetto U, Bolliger D, Von Heymann C, et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg. 2018;53(1):79–111.
Google Scholar
Johansson PI, Sølbeck S, Genet G, Stensballe J, Ostrowski SR. Coagulopathy and hemostatic monitoring in cardiac surgery: an update. Scand Cardiovasc J SCJ. 2012;46(4):194–202.
Google Scholar
Peterson JA, Maroney SA, Zwifelhofer W, Wood JP, Yan K, Bercovitz RS, et al. Heparin–protamine balance after neonatal cardiopulmonary bypass surgery. J Thromb Haemost. 2018;16(10):1973–83.
Google Scholar
Walley H, Yacoub M, Saad H. Pharmacological management of perioperative bleeding in cardiac surgery. Glob Cardiol Sci Pract [Internet]. 2017;2:12.
Wasowicz M, Meineri M, McCluskey SM, Mitsakakis N, Karkouti K. The utility of thromboelastography for guiding recombinant activated factor VII therapy for refractory hemorrhage after cardiac surgery. J Cardiothorac Vasc Anesth. 2009;23(6):828–34.
Google Scholar
Raphael J, Mazer CD, Subramani S, Schroeder A, Abdalla M, Ferreira R, et al. Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients. Anesth Analg. 2019;129(5):1209–21.
Google Scholar
Tibi P, McClure RS, Huang J, Baker RA, Fitzgerald D, Mazer CD, et al. STS/SCA/AmSECT/SABM update to the clinical practice guidelines on patient blood management. J Extra Corpor Technol. 2021;53(2):97–124.
Google Scholar
Kietaibl S, Ahmed A, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe peri-operative bleeding: guidelines from the european society of anaesthesiology and intensive care: second update 2022. Eur J Anaesthesiol. 2023;40(4):226–304.
Google Scholar
Erdoes G, Birschmann I, Nagler M, Koster A. Personalizing management of antiplatelet therapy in cardiac surgery: the ongoing need to nourish “dry land.” J Cardiothorac Vasc Anesth. 2025;39(4):873.
Google Scholar
Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 1998;65(3):712–8.
Google Scholar
Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg. 2011;113(6):1319–33.
Google Scholar
Sarkar M, Prabhu V. Basics of cardiopulmonary bypass. Indian J Anaesth. 2017;61(9):760.
Google Scholar
Ferreira LO, Vasconcelos VW, Lima JDS, Vieira Neto JR, Da Costa GE, Esteves JDC, et al. Biochemical changes in cardiopulmonary bypass in cardiac surgery: new insights. J Pers Med. 2023;13(10):1506.
Google Scholar
Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost JTH. 2021;19(3):617–32.
Google Scholar
Yasuda N, Goto K, Kuribayashi Y, Ohchi Y, Kitano T. Incidence, outcome, and risk factors of cardiovascular surgery-associated disseminated intravascular coagulation: a single-center retrospective study. J Clin Med. 2022;11(13):3633.
Google Scholar
Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost. 2021;19(3):617–32.
Google Scholar
Baumann Kreuziger L, Karkouti K, Tweddell J, Massicotte MP. Antithrombotic therapy management of adult and pediatric cardiac surgery patients. J Thromb Haemost. 2018;16(11):2133–46.
Google Scholar
Chen Y, Phoon PHY, Hwang NC. Heparin resistance during cardiopulmonary bypass in adult cardiac surgery. J Cardiothorac Vasc Anesth. 2022;36(11):4150–60.
Google Scholar
Lee MH, Beck M, Shann K. Protamine dose to neutralize heparin at the completion of cardiopulmonary bypass can be reduced significantly without affecting post-operative bleeding. J Extracorpor Technol. 2023;55(3):105–11.
Maier CL, Connors JM, Levy JH. Troubleshooting heparin resistance. Hematology. 2024;2024(1):186–91.
Google Scholar
Avidan MS, Levy JH, Van Aken H, Feneck RO, Latimer RD, Ott E, et al. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;130(1):107–13.
Google Scholar
Klein A, Agarwal S, Cholley B, Fassl J, Griffin M, Kaakinen T, et al. A review of European guidelines for patient blood management with a particular emphasis on antifibrinolytic drug administration for cardiac surgery. J Clin Anesth. 2022;78: 110654.
Google Scholar
McEvoy MD, Reeves ST, Reves JG, Spinale FG. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg. 2007;105(4):949–62.
Google Scholar
Heuts S, Ceulemans A, Kuiper GJAJM, Schreiber JU, Van Varik BJ, Olie RH, et al. Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice. Eur J Cardiothorac Surg. 2023;64(4):340.
Tellor BR, Smith JR, Prasad SM, Joseph SM, Silvestry SC. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. J Heart Lung Transplant. 2014;33(1):94–101.
Google Scholar
Sembi N, Cheng T, Ravindran W, Ulucay E, Ahmed A, Harky A. Anticoagulation and antiplatelet therapy post coronary artery bypass surgery. J Card Surg. 2021;36(3):1091–9.
Google Scholar
Ortmann E, Klein AA, Sharples LD, Walsh R, Jenkins DP, Luddington RJ, et al. Point-of-care assessment of hypothermia and protamine-induced platelet dysfunction with multiple electrode aggregometry (multiplate®) in patients undergoing cardiopulmonary bypass. Anesth Analg. 2013;116(3):533–40.
Google Scholar
Meesters MI, Von Heymann C. Optimizing perioperative blood and coagulation management during cardiac surgery. Anesthesiol Clin. 2019;37(4):713–28.
Google Scholar
Boer C, Meesters MI, Veerhoek D, Vonk ABA. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth. 2018;120(5):914–27.
Google Scholar
Aubourg R, Putzolu J, Bouche S, Galmiche H, Denis C, d’Andon A, et al. Surgical hemostatic agents: assessment of drugs and medical devices. J Visc Surg. 2011;148(6):e405–8.
Google Scholar
Daud A, Kaur B, McClure GR, Belley-Cote EP, Harlock J, Crowther M, et al. Fibrin and thrombin sealants in vascular and cardiac surgery: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2020;60(3):469–78.
Google Scholar
Novotny R, Hlubocký J, Mitáš P, Lindner J. Fibrin sealants in cardiac surgery: the last five years of their development and application. Adv Clin Exp Med. 2018;27(6):857–62.
Google Scholar
Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood. 1990;76(10):2011–6.
Google Scholar
Tackett SM, Calcaterra D, Magee G, Lattouf OM. Real-world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(6):1558–65.
Google Scholar
Abbasi T, Emadi E, Hamidi A. Autologous platelet-rich plasma fibrin-glue reduces bleeding after coronary artery bypass grafting, a randomized clinical study. Hippokratia. 2022;26(4):143–6.
Google Scholar
Ise H, Kitahara H, Oyama K, Takahashi K, Kanda H, Fujii S, et al. Hypothermic circulatory arrest induced coagulopathy: rotational thromboelastometry analysis. Gen Thorac Cardiovasc Surg. 2020;68(8):754–61.
Google Scholar
Tachias F, Samara E, Petrou A, Karakosta A, Siminelakis S, Apostolakis E, et al. The effect of cell salvage on bleeding and transfusion needs in cardiac surgery. Anesthesiol Res Pract. 2022;2022:1–8.
Annich GM. Extracorporeal life support: the precarious balance of hemostasis. J Thromb Haemost. 2015;13:S336–42.
Google Scholar
Becker S, Lang H, Vollmer Barbosa C, Tian Z, Melk A, Schmidt BMW. Efficacy of CytoSorb®: a systematic review and meta-analysis. Crit Care. 2023;27(1):215.
Google Scholar
Šoltés J, Skribuckij M, Říha H, Lipš M, Michálek P, Balík M, et al. Update on anticoagulation strategies in patients with ECMO—a narrative review. J Clin Med. 2023;12(18):6067.
Google Scholar
Durante A, Limite LR, Peretto G, Laricchia A, Ancona F, Mangieri A, et al. Pharmacological and nonpharmacological treatment after cardiac surgery. Cardiol Rev. 2014;22(5):199–209.
Google Scholar
McGill N. Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ. 2002;324(7349):1299–1299.
Google Scholar
Aramendi JI, Mestres CA, Martinez-León J, Campos V, Muñoz G, Navas C. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial☆. Eur J Cardiothorac Surg. 2005;27(5):854–60.
Google Scholar
Khalil PN, Siebeck M, Ismail M, Khalil MN, von Knobelsdorff G, Marx G, et al. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery. Eur J Med Res. 2006;11(9):386–93.
Google Scholar
Ahmed AB, Koster A, Lance M, Faraoni D. European guidelines on perioperative venous thromboembolism prophylaxis: cardiovascular and thoracic surgery. Eur J Anaesthesiol. 2018;35(2):84–9.
Google Scholar
Anderson E, Dyke C, Levy JH. Anticoagulation strategies for the management of postoperative atrial fibrillation. Clin Lab Med. 2014;34(3):537–61.
Google Scholar
Tang M, Wierup P, Terp K, Ingerslev J, Sørensen B. Cardiac surgery in patients with haemophilia. Haemophilia. 2009;15(1):101–7.
Google Scholar
Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117(3):531–47.
Google Scholar
Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA. Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth. 2013;27(4):S20-34.
Google Scholar
Haensig M, Kempfert J, Kempfert PM, Girdauskas E, Borger MA, Lehmann S. Thrombelastometry guided blood-component therapy after cardiac surgery: a randomized study. BMC Anesthesiol. 2019;19(1):201.
Google Scholar
Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, Grocott HP, et al. Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circulation. 2016;134(16):1152–62.
Google Scholar
Karanjkar A, Kapoor PM, Sharan S, Bhardwaj V, Malik V, Hasija S, et al. A prospective randomized clinical trial of efficacy of algorithm-based point of care guided hemostatic therapy in cyanotic congenital heart disease surgical patients. J Card Crit Care TSS. 2019;03(01):08–16.
Chakraborty S, Kapoor PM, Rajashekar P, Devagourou V, Patidar G, Mathiyalagen P. Prospective interventional cohort study using aiims simplified POC algorithm for restricted blood transfusion in cyanotic children. J Card Crit Care TSS. 2024;24(8):195–204.
Görlinger K, Pérez-Ferrer A, Dirkmann D, Saner F, Maegele M, Calatayud ÁAP, et al. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean J Anesthesiol. 2019;72(4):297–322.
Google Scholar
Despotis G, Avidan M, Eby C. Prediction and management of bleeding in cardiac surgery. J Thromb Haemost. 2009;7:111–7.
Google Scholar
Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Emergency and Critical Care Group, editor. Cochrane Database Syst Rev [Internet]. 2016 Aug 22 [cited 2024 Sep 20];2018(12). Available from: http://doi.wiley.com/https://doi.org/10.1002/14651858.CD007871.pub3
Smith MM, Schroeder DR, Nelson JA, Mauermann WJ, Welsby IJ, Pochettino A, et al. Prothrombin complex concentrate vs plasma for post-cardiopulmonary bypass coagulopathy and bleeding: a randomized clinical trial. JAMA Surg. 2022;157(9):757.
Google Scholar
Vives M, Hernandez A, Parramon F, Estanyol N, Pardina B, Muñoz A, et al. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renov Dis. 2019;12:153–66.
Google Scholar
Yousuf MS, Samad K, Ahmed SS, Siddiqui KM, Ullah H. Cardiac Surgery and Blood-Saving Techniques: An Update. Cureus [Internet]. 2022 Jan 13 [cited 2024 Sep 19]; Available from: https://www.cureus.com/articles/80583-cardiac-surgery-and-blood-saving-techniques-an-update
Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg. 2008;34(1):73–92.
Google Scholar
Baryshnikova E, Ranucci M. Point-of-care haemostasis and coagulation monitoring in cardiac surgery at IRCCS Policlinico San Donato. Eur Heart J Suppl. 2016;18(suppl E):E42–8.
Google Scholar
Erdoes G, Schloer H, Eberle B, Nagler M. Next generation viscoelasticity assays in cardiothoracic surgery: feasibility of the TEG6s system. PLoS ONE. 2018;13(12):e0209360.
Google Scholar
Naguib AN, Carrillo SA, Corridore M, Bigelow AM, Walczak A, Tram NK, et al. A ROTEM-guided algorithm aimed to reduce blood product utilization during neonatal and infant cardiac surgery. J Extracorpor Technol. 2023;55(2):60–9.
Hoffmann RF, Horsten S, Mariani MA, De Vries AJ. Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the hemochron® response and hemochron® signature elite. Perfusion. 2023;38(2):285–91.
Google Scholar
Xu H, Su S, Tang W, Wei M, Wang T, Wang D, et al. Comparison of the performance of the warfarin pharmacogenetics algorithms in patients with surgery of heart valve replacement and heart valvuloplasty. Thromb Res. 2015;136(3):552–9.
Google Scholar
Choudhary SK, Mathew AB, Parhar A, Hote MP, Talwar S, Rajashekhar P. Genetic polymorphisms and dosing of vitamin K antagonist in Indian patients after heart valve surgery. Indian J Thorac Cardiovasc Surg. 2019;35(4):539–47.
Google Scholar
Filippelli A, Signoriello S, Bancone C, Corbi G, Manzo V, Iesu S, et al. Prospective validation of the international warfarin pharmacogenetics consortium algorithm in high-risk elderly people (VIALE study). Pharmacogenomics J. 2020;20(3):451–61.
Google Scholar
Hikino K, Koido M, Ide K, Nishimura N, Terao C, Mushiroda T, et al. Individual variation in unfractionated heparin dosing after pediatric cardiac surgery. Sci Rep. 2020;10(1):19438.
Google Scholar
Liu J, Jiang HH, Wu DK, Zhou YX, Ye HM, Li X, et al. Effect of gene polymorphims on the warfarin treatment at initial stage. Pharmacogenomics J. 2017;17(1):47–52.
Google Scholar
Topkara VK, Knotts RJ, Jennings DL, Garan AR, Levin AP, Breskin A, et al. Effect of CYP2C9 and VKORC1 gene variants on warfarin response in patients with continuous-flow left ventricular assist devices. ASAIO J. 2016;62(5):558–64.
Google Scholar
Ma TKW, Lam Y, Tan VP, Yan BP. Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions? Br J Clin Pharmacol. 2011;72(4):697–706.
Google Scholar
Ghadimi K, Levy JH, Welsby IJ. Perioperative management of the bleeding patient. Br J Anaesth. 2016;117:18–30.
Head SJ, Çelik M, Kappetein AP. Mechanical versus bioprosthetic aortic valve replacement. Eur Heart J. 2017;38(28):2183–91.
Google Scholar
Ranucci M. Hemostatic and thrombotic issues in cardiac surgery. Semin Thromb Hemost. 2015;41(01):084–90.
Masi P, Gendreau S, Moyon Q, Leguyader M, Lebreton G, Ropers J, et al. Bleeding complications, coagulation disorders, and their management in acute myocardial infarction-related cardiogenic shock rescued by veno-arterial ECMO: A retrospective cohort study. J Crit Care. 2024;82: 154771.
Google Scholar
Boyle EM, Verrier ED, Spiess BD. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg. 1996;62(5):1549–57.
Google Scholar
Aneman A, Brechot N, Brodie D, Colreavy F, Fraser J, Gomersall C, et al. Advances in critical care management of patients undergoing cardiac surgery. Intensive Care Med. 2018;44(6):799–810.
Google Scholar
Boucher AA, Heneghan JA, Jang S, Spillane KA, Abarbanell AM, Steiner ME, et al. A narrative review of postoperative anticoagulation therapy for congenital cardiac disease. Front Surg. 2022;14(9): 907782.
Moldovan H, Antoniac I, Gheorghiță D, Safta MS, Preda S, Broască M, et al. Biomaterials as haemostatic agents in cardiovascular surgery: review of current situation and future trends. Polymers. 2022;14(6):1189.
Google Scholar
Bruckner BA, Ngo U, Ramchandani M, Suarez E, Awad S, Reardon M. Application techniques of a novel hemostat in cardiac operations: HEMOBLAST. J Card Surg. 2019;34(9):849–53.
Google Scholar
Kim HJ, Shin HJ, Lee SW, Heo S, Lee SH, Kim JE, et al. Improvement of transfusion practice in cardiothoracic surgery through implementing a patient blood management program. J Chest Surg. 2024;57(4):390–8.
Google Scholar
Gottlieb EA, Andropoulos DB. Current and future trends in coagulation management for congenital heart surgery. J Thorac Cardiovasc Surg. 2017;153(6):1511–5.
Google Scholar
Thiruvenkatarajan V, Pruett A, Adhikary S. Coagulation testing in the perioperative period. Indian J Anaesth. 2014;58(5):565.
Google Scholar
Mumtaz H, Saqib M, Ansar F, Zargar D, Hameed M, Hasan M, et al. The future of cardiothoracic surgery in artificial intelligence. Ann Med Surg. 2022.
Abri QA, Von Ballmoos MCW. Cardiovascular surgery procedural training and evaluation: current status and future directions. Methodist DeBakey Cardiovasc J. 2022;18(3):30–8.
Google Scholar
Stevens LM, Cooper JB, Raemer DB, Schneider RC, Frankel AS, Berry WR, et al. Educational program in crisis management for cardiac surgery teams including high realism simulation. J Thorac Cardiovasc Surg. 2012;144(1):17–24.
Google Scholar
Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants. Chest. 2012;141(2):e24S-e43S.
Google Scholar
Mazzeffi M, Strauss E, Meyer M, Hasan S, Judd M, Abuelkasem E, et al. Coagulation factor levels and underlying thrombin generation patterns in adult extracorporeal membrane oxygenation patients. Anesth Analg. 2019;129(3):659–66.
Google Scholar
Koster A, Erdoes G, Nagler M, Birschmann I, Alberio L. How would we treat our own heparin-induced thrombocytopenia during cardiac surgery? J Cardiothorac Vasc Anesth. 2021;35(6):1585–93.
Google Scholar
Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52(4):665–72.
Google Scholar
Şanal L, Günaydın S, Tatar M. Cost-effectiveness and budget impact analyses of patient blood management in a cardiovascular surgery department at ankara bilkent city hospital in Turkey. Adv Ther. 2024;41(2):716–29.
Google Scholar
Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358(12):1229–39.
Google Scholar
Casselman FPA, Lance MD, Ahmed A, Ascari A, Blanco-Morillo J, Bolliger D, et al. EACTS/EACTAIC guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2024;10:352.
Myles PS, Smith JA, Kasza J, Silbert B, Jayarajah M, Painter T, et al. Tranexamic acid in coronary artery surgery: one-year results of the aspirin and tranexamic acid for coronary artery surgery (ATACAS) trial. J Thorac Cardiovasc Surg. 2019;157(2):644-652.e9.
Google Scholar
Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation. 2008;117(4):478–84.
Google Scholar
Ko D, Lin KJ, Bessette LG, Lee SB, Walkey AJ, Cheng S, et al. Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010–2020. JAMA Netw Open. 2022;5(11): e2242964.
Google Scholar
Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017;377(22):2133–44.
Google Scholar
Despotis GJ, Gravlee G, Filos K, Levy J, Fisher DM. Anticoagulation monitoring during cardiac surgery. Anesthesiology. 1999;91(4):1122–1122.
Google Scholar
Kamali F, Wynne H. Pharmacogenetics of warfarin. Annu Rev Med. 2010;61(1):63–75.
Google Scholar
Merry A. Thrombin inhibitors and cardiopulmonary bypass. J Extracorpor Technol. 2006;38(1):52–6.
Despotis GJ, Avidan MS, Hogue CW. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg. 2001;72(5):S1821–31.
Google Scholar
Gkiouliava A, Argiriadou H, Antonitsis P, Goulas A, Papapostolou E, Sarridou D, et al. Individualized heparin monitoring and management reduces protamine requirements in cardiac surgery on minimal invasive extracorporeal circulation. A Prospect Randomized Study Perfus. 2024;39(8):1595–604.
Bjørnstad JL, Khan AM, Røed-Undlien H, Bendz B, Nygård S, Hoel TN, et al. Operative survival in patients with acute aortic disease in the era of newer oral anticoagulants. Open Heart. 2020;7(2): e001278.
Google Scholar
link
More Stories
Median Arcuate Ligament Syndrome | Orlando surgeon explains signs, symptoms and treatment
Gyder Surgical announces first commercial surgical cases in the United States performed by Dr. Paul M. Lombardi, M.D., at the Tri-County Orthopedics’ Joint Replacement Institute outpatient center
Bunion Surgery Market Get Facts About Business Strategies 2026 to 2031: Medi-tech Insights